Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non‐invasive prediction of fetal growth restriction by whole‐genome promoter profiling of maternal plasma DNA: a nested case–control study

4 May 2020

Abstract excerpt

OBJECTIVE: To predict fetal growth restriction (FGR) by whole-genome promoter profiling of maternal plasma. DESIGN: Nested case-control study. SETTING: Hospital-based. POPULATION OR SAMPLE: 810 pregnancies: 162 FGR cases and 648 controls. METHODS: We identified gene promoters with a nucleosome footprint that differed between FGR cases and controls based on maternal plasma cell-free DNA (cfDNA) nucleosome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Associations and Epidemiology
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32364311
DOI: 10.1111/1471-0528.16292

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non‐invasive prediction of fetal growth restriction by whole‐genome promoter profiling of maternal plasma DNA: a nested case–control studyPMID 32364311Read ↗

Genome-wide nucleosome footprints of plasma cfDNA predict preterm birth: A case-control studySemantic proximity Read ↗

Whole‐Genome Promoter Profiling of Plasma DNA Exhibits Diagnostic Value for Placenta‐Origin Pregnancy ComplicationsSemantic proximity Read ↗

Maternal plasma cell-free DNA nucleosome footprints can reveal changes in gene expression profiles during pregnancy and pre-eclampsiaSemantic proximity Read ↗

Preeclampsia risk prediction from prenatal cell-free DNA screeningSemantic proximity Read ↗

Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factorsSemantic proximity Read ↗

Gene expression profiles based on maternal plasma cfDNA nucleosome footprints indicate fetal development and maternal immunity changes during pregnancy progressSemantic proximity Read ↗

Exploration of cfDNA landscape in NIPT and clinical utilities of cfDNA based gene expression inference in prenatal diagnosticsSemantic proximity Read ↗

Integrated transcriptomic analysis and machine learning for characterizing diagnostic biomarkers and immune cell infiltration in fetal growth restrictionSemantic proximity Read ↗

The Genetic Etiology Diagnosis of Fetal Growth Restriction Using Single-Nucleotide Polymorphism-Based Chromosomal Microarray AnalysisSemantic proximity Read ↗

Sex-Biased lncRNA Signature in Fetal Growth Restriction (FGR)Semantic proximity Read ↗

Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.Semantic proximity Read ↗

Genome-wide maps of distal gene regulatory regions active in the human placentaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.